Both the genetic deficiency of CatB and its pharmacological inhibition by CA-074Me ameliorated microglia-mediated neuroinflammation and cognitive impairment of Pg LPS-treated middle-aged mice [12]. This evidence concerns the gene TYRP1 and Cognitive impairment.